TNFSF10 and glioblastoma: However, in glioblastoma, the low expression of the death receptor (DR4 and DR5) and high expression of cFLIP, a master anti-apoptotic regulator molecule, led to the glioblastoma-derived CSCs resistance to TRAIL [153].